Compare IDEXX Laboratories, Inc. (IDXX) vs ServiceNow Inc (NOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs ServiceNow Inc — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while ServiceNow Inc trades at $140.86 (market cap $144.48B). The key difference: ServiceNow Inc is far larger — about 3.6× IDEXX Laboratories, Inc.'s market cap, and ServiceNow Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and ServiceNow Inc for 54 Days on average.
| IDXX | NOW | |
|---|---|---|
Market Cap | $40.43B | $144.48B |
Volume | 692,164 | 11,801,699 |
Sector | Health | Technology |
52-Week High | $766.68 | $189.26 |
52-Week Low | $504.70 | $83.00 |
Typical Hold Time | 46 Days | 54 Days |
Enterprise Value | $41.32B | $148.27B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $518.00, up 2.24% with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and product expansions highlight growth initiatives. Analyst consensus remains bullish with a $665 price target, though technical indicators suggest near-term caution.
Outlook remains positive driven by diagnostic innovation and recurring revenue growth, but faces headwinds from FX volatility and weaker U.S. vet visits. The 36.06 P/E ratio reflects premium valuation, requiring sustained execution. Risks include competitive pressures and insider selling, while institutional ownership trends show mixed signals.
ServiceNow (NOW) trades at $139.75, up 1.36% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with $13.28B revenue in 2025, 74.77% gross margins, and consistent earnings beats. Recent AI product growth exceeding $1B annual contract value and positive market sentiment position the stock for potential upside toward the $146.04 consensus target.
Outlook remains positive with AI-driven growth catalysts, though premium valuation (P/E 87.34) and competitive pressures present risks. Wall Street maintains strong buy sentiment (87% buy ratings) with institutional confidence in the company's enterprise software leadership and AI integration strategy supporting long-term growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About ServiceNow Inc
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management (ITSM), expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service (PaaS).
Read more on NOW →
